The biotech sector has been rallying as of late, evidenced by the S&P 500 Biotechnology Index up close to 9% within the past month. Of course, as we’ve seen so far in 2022, rallies are difficult to sustain given the market uncertainty. Interest rates will continue to be a prime focus in...